Methods: Cases report study of moderate to severe COVID-19 patients aged 12 years and older, with a confirmed diagnosis of SARS-CoV-2 by real-time PCR test, who were treated with Remdesivir plus Tocilizumab at Vinmec Central Park from August 1, 2021 to November 30, 2021.